PHARMACEUTICAL COMPOSITION COMPRISING A JAPANESE ENCEPHALITIS VIRUS FOR ADMINISTRATION TO A SPECIFIC PATIENT POPULATION

摘要

The present invention relates to a pharmaceutical composition comprising a cell culture derived, inactivated JEV for use in the treatment or prevention of an infection with JEV in a human subject with at least 40 years of age. Furthermore, the invention relates to the use of a cell culture derived, inactivated JEV for the preparation of a pharmaceutical composition for the treatment or prevention of an infection with JEV, wherein the pharmaceutical composition is administered to a human subject with at least 40 years of age. The present invention also relates to a method for treating or preventing an infection with JEV, comprising the step of administering a therapeutically effective amount of a pharmaceutical composition comprising a cell culture derived, inactivated JEV to a human subject with at least 40 years of age. In another aspect, the invention relates to a pharmaceutical composition comprising a JEV for use in the treatment or prevention of an infection with JEV in a subject which has previously been vaccinated with a TBEV vaccine. In still another aspect, the invention relates to the use of a JEV for the preparation of a pharmaceutical composition for the treatment or prevention of an infection with JEV, wherein the pharmaceutical preparation is administered to a subject which has previously been vaccinated with a TBEV vaccine. The invention further relates to a method for treating or preventing an infection with JEV, comprising the steps of administering a therapeutically effective amount of a TBEV vaccine to a subject, and subsequently administering a therapeutically effective amount of a pharmaceutical composition comprising a JEV to said subject.